Related Experiment Videos
Ethical considerations in neuroclinical trials
1Department of Physical Medicine and Rehabilitation, University of Virginia Medical School, Charlottesville, USA.
Neurosurgical Review
|January 1, 1997
Summary
Investigators must prioritize ethical considerations for neuroclinical trials (NCT). Early attention to risk-benefit analysis, methodology, and informed consent is crucial for Institutional Review Board (IRB) approval.
Area of Science:
- Neuroscience
- Clinical Research Ethics
- Medical Ethics
Background:
- Ethical decision-making is increasingly critical in clinical trial reviews.
- Neuroclinical Trials (NCT) present unique ethical challenges for researchers.
Purpose of the Study:
- To review ethical concepts relevant to neuroclinical trials.
- To guide investigators on ethical concerns before Institutional Review Board (IRB) submission.
Main Methods:
- Review of ethical concepts applicable to NCT.
- Discussion of risk-benefit analysis, methodology (randomization, placebo, design), and consent (informed, deferred, waived).
- Description of Office for Protection from Research Risk (OPRR) guidelines.
Main Results:
- Investigators face heightened ethical scrutiny from IRBs for NCT proposals.
- Proactive consideration of ethical issues is essential during trial planning.
Conclusions:
- Early attention to ethical considerations is recommended for investigators proposing NCT.
- Thorough justification of ethical concerns is required prior to IRB submission.
Keywords:
Biomedical and Behavioral Research